These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38376700)

  • 21. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
    El-Saed A; Voigt A; Shalaby A
    Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography.
    Kawabe M; Sato A; Hoshi T; Endo M; Yoshida I; Aonuma K
    J Cardiol; 2017 Apr; 69(4):671-677. PubMed ID: 27443597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke.
    Koenig MA; Puttgen HA; Prabhakaran V; Reich D; Stevens RD
    Intensive Care Med; 2007 Sep; 33(9):1587-93. PubMed ID: 17541542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.
    Feldman AM; Mann DL; She L; Bristow MR; Maisel AS; McNamara DM; Walsh R; Lee DL; Wos S; Lang I; Wells G; Drazner MH; Schmedtje JF; Pauly DF; Sueta CA; Di Maio M; Kron IL; Velazquez EJ; Lee KL
    Circ Heart Fail; 2013 May; 6(3):461-72. PubMed ID: 23584092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
    Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of B-type natriuretic peptide with coronary plaque subtypes detected by coronary computed tomography angiography in patients with stable chest pain.
    Yang Y; Li C; Zhao L
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1599-1606. PubMed ID: 28396960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of BNP and tumour marker CA125 in patients with heart failure.
    Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
    Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50.
    Berg DD; Freedman BL; Bonaca MP; Jarolim P; Scirica BM; Goodrich EL; Sabatine MS; Morrow DA
    J Am Heart Assoc; 2021 May; 10(9):e018673. PubMed ID: 33884889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responder to BNP-guided treatment in heart failure. The process of defining a responder.
    Karlström P; Dahlström U; Boman K; Alehagen U
    Scand Cardiovasc J; 2015; 49(6):316-24. PubMed ID: 26153427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.
    Koitabashi T; Inomata T; Niwano S; Nishii M; Takeuchi I; Nakano H; Shinagawa H; Takehana H; Izumi T
    Int Heart J; 2005 May; 46(3):453-64. PubMed ID: 16043941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma level of apelin with NYHA grade II and III but not IV.
    Han L; Jie B; Luo J; Chen L; Jia Y; Guo L; Zhao Y; Chen X; Zhu X; Teng X; Qi Y
    Amino Acids; 2020 May; 52(5):823-829. PubMed ID: 32388793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
    Hirakawa K; Yamamuro M; Uemura T; Takashio S; Kaikita K; Utsunomiya D; Nakayama M; Yamamoto E; Yamashita Y; Hokimoto S; Tsujita K
    Int J Cardiol; 2017 Feb; 228():881-885. PubMed ID: 27889555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
    Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
    J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Rogers RK; May HT; Anderson JL; Muhlestein JB
    Am Heart J; 2009 Nov; 158(5):777-83. PubMed ID: 19853697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.